Keen, Nick
Novartis (United States)
2 papers on CoChat
Most cited papers
- Verified
Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor
Garcia Fortanet, J., Chen, C. H.-T., Chen, Y.-N. P., Chen, Z., Deng, Z., Firestone, B., Fekkes, P., Fodor, M., Fortin, P. D., Fridrich, C., et al. (2016) · Journal of Medicinal Chemistry
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 298
- Verified
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer
LaMarche, M. J., Acker, M., Argintaru, A., Bauer, D., Boisclair, J., Chan, H., Chen, C. H.-T., Chen, Y.-N., Chen, Z., Deng, Z., et al. (2020) · Journal of Medicinal Chemistry
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 231
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free